H p F 1 198 1 ll t E I 4011 the " 1 1 in 8.8% 电影 en HD 1999 1 I I TI i r I 1982 i Income. 40 F H TICH STATE P 196 H 1 1 18 la lar 4-0 E 1 THE OWNER 1 - 1 8 luismmolina Merus N.V. (NASDAQ:MRUS) is a Dutch company that has seen its stock nearly triple since I covered it in April last year. At that time, I had some doubts about its lead molecule zenocutuzumab, a HER2 and HER3 targeting bispecific molecule targeting NRG1+ cancer as monotherapy. My doubts came from the small and early stage nature of the registr ...